Take a walk on the high street of most UK towns and you'll see brands providing a range of consumer healthcare services, from skincare and dentistry to fertility and sport and exercise medicine specialists.
Despite concerns over broader discretionary consumer spend, many of us are taking an increasingly proactive approach to our mental and physical wellbeing and therefore spending in this space remains resilient.
Corporate activity and M&A volumes have increased sharply in the private pay consumer healthcare services market, driven by the global obsession with health, wellness and beauty. The UK’s consumer healthcare market saw 22 transactions complete in the first nine months of 2019, compared to just 16 in the whole of 2018.
This is a market characterised by corporate M&A volume and interest from institutional investors. We’ve analysed the key value drivers in this attractive market which support a broad range of transaction multiples.
M&A volumes in consumer healthcare services are up almost 40% so far this year compared to the whole of 2018. We’re seeing both corporate and financial investor activity driving the market and this is creating significant opportunities for our clients.